TGA Approval

IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial (439213)

ARTG ID

439213

ARTG Name

IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial

Sponsor

Eugia Pharma (Australia) Pty Ltd

ARTG Date

March 17, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

EUGIA PHARMA (AUSTRALIA) PTY LTD

https://medical-cdn.nocode.com/drug_tga/13dfc258ed9e503b9148aec6bf267f20.pdf

https://medical-cdn.nocode.com/drug_tga/d92fdacddaabb1f3e7ca72a42e27b905.pdf

Ingredient Name

irinotecan hydrochloride trihydrate

Empowering clinical research with data-driven insights and AI-powered tools.

IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial (439213) - TGA 批准文号 | MedPath